U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07271342) titled 'Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China' on Nov. 28.
Brief Summary: The ORIENTAL study is a prospective, multicenter, continuously enrolled real-world cohort designed to evaluate the effectiveness and safety of intravenous tenecteplase for acute ischemic stroke (AIS) in routine clinical practice across China. Approximately 10,000 patients from about 200 hospitals will be included. Eligible adults with imaging-confirmed AIS who receive tenecteplase as part of standard care will be consecutively enrolled and followed through 90 days. The study will describe patient characteris...